Pressurl: https://news.google.com/rss/articles/CBMilgFBVV95cUxPYUVKWGtHdUtUOVdFbzREMmNmWjhYRW8yWXFORGNjWlh4SFBnQjdXVUlXckI3ZVp5QTFkdFVUR0hqUTM2RmxaZ0hmV2ZUenVkclNGdlVvZUhCb2dYMFpyZmhxY3pZMVphUU9WckdSWUZSLUJuTzc5VW9sVHJ3Y00yVlR0VnBwZ0ZhblZZcHN4OHZVZDRibnfSAZsBQVVfeXFMTXJUSmk5b2tfemlSZm5tNkR2Ty1jSXBYWEFud3ZaSVlVMVBCa3VCdWVQSExXZFBXQ0F5RFdCSG1JRXpteHVKQUNCMzdsazBpVGpzeGotdTZzTHpJZS1QNEstWTZvTDRvWmVwNTg4a0xKVGpfcVRBcnpUdzVQUm9TTTlrelpmYnktd1NPUDBLV0duMVhMYnV3WjhkYVU?oc=5 · headline: R1 Therapeutics: $77.5 Million Raised To Advance Kidney Disease Treatment · publication: Pulse 2.0google_news · 10/1/2026
Pressurl: https://news.google.com/rss/articles/CBMinAFBVV95cUxNbFhRVVd2YWZRVVZqZHg5VXNjN0RTRHhsekV3RjU5RTdrNm5Iel9nQTJYSW1YN1luekx2SE1LVmgwdjZRclRXdG1xVGVwTWZ1NjM2eUg3NlBsd3dfT3FyQWY5bEhya0tFaHNLWmNLZk56QUx2ZnRZZ1dKWExpaHVfNkZPTFVzYzlFVlc1dzRsOUZmVmplSy1Sb25uSXk?oc=5 · headline: R1 Therapeutics debuts with $77.5m to tackle kidney disease · publication: BioXconomygoogle_news · 10/1/2026
Pressurl: https://news.google.com/rss/articles/CBMihAFBVV95cUxPUjdZVGI0LUVRc3VZMXpKX1BpazhLWC1NX3NOSmpUaDAwMUVjU1FPVzlkWnB1Z0w2Nl9ZaXNFNVBzXzE3YnVPWV9ZRVBzSVJ0NzRseVZlRXRwWTY5VXZ1bV9uT2FYdmg5ZmdEY09EcVhPdTVzUm01R0lIT0VuNWJSaFVkS00?oc=5 · headline: R1 Therapeutics Extends Series A To $80.5M · publication: finsmes.comgoogle_news · 10/1/2026
Pressurl: https://news.google.com/rss/articles/CBMi5AFBVV95cUxQbW1PZ0Z5OEd2c3Nrc1lIUnZMUjVhMHo1N0xfYVlFVHRya2N0WEt2eGxuM3ZUTGlNN2NjYi1sSS1hTzR6YjFjdGc3dGM1UzJ6M0l5ODVtNFhOWFRkcDIxdjFoY1VQczB3Q0ZLWlJtMkhmVkdoSjB3Z2ZZSFVEOVFoYXE1UWtoTEtnNFktWnVBdmc1aGlUR2phMmVSUmRGN0p3aG5teFBiUE4xLWVOc0dZVkFEejBXWkFtdHdqal93cjFhbmxkX2xsMjM1aXBDQ1lDR3BZUzJ1c0t5LVl2clhtTG5OTzQ?oc=5 · headline: R1 Therapeutics launches with $78 million funding round, secures kidney disorder treatment license · publication: Reuters
google_news · 10/1/2026
Pressurl: https://news.google.com/rss/articles/CBMinAFBVV95cUxOUk1MTHpaRFdtZm1qSkJMR3phX2ZmMUttY3dOTUN6UXlJTl9jN0ViQ0p2YUQtcGlXRklob2hmSmFELWphTTA1ZTYtZ0hHZ3JoTGVYSFdFMFFnSmtJQTlLQVM2MWhHZDZ5MHJ3NlN0N2VTVzVDNlNxY0xfcUUtd1RDdGI0UW83bDJoTnNwSHk5ZEhLVVJVNVJmdFI4UFY?oc=5 · headline: R1 Therapeutics raises $77.5m to progress AP306 for hyperphosphatemia · publication: Pharmaceutical Technologygoogle_news · 10/1/2026
Pressurl: https://news.google.com/rss/articles/CBMikgFBVV95cUxOVXRyTXVXQWlJYTJuWTNnYkxZSVZkZXp4RTA4TUFDeVR2THdMdmxrcGtBemIzNXl2cXFsdUFpSFhSNGotQmRXQlJBN082cE5EdHFkMXg2M3ZTckpKQWxWMXFHOHViMVdzNGZ6T1lYRERfYTJ4eFZILWJIZWdKTloyd0NmY3hxdVdxQ3AwdVpGVFBlUQ?oc=5 · headline: R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease · publication: Yahoo Financegoogle_news · 10/1/2026
Pressurl: https://news.google.com/rss/articles/CBMipwFBVV95cUxPYThQM0stS0ZmTE5vS3p5clVJY0lMZjl4YkdJcXAwNHpRdzliNmctNU55T3NxNUs2WEZ0RWpPWE1kdnk1TVVXdmxlLXo4eDJ3RWdHaURWRUxSOGJWcVVxbTRkUWs3bjBsSG9JNEZxNlExUDY4akxUWkxONXBEWTZUdmZZNVdkTXFiblpJb0pub2t1dlNCdnNhdGlFLVAzQzRzM1FwTDk0TQ?oc=5 · headline: R1 Therapeutics launches with $77.5m to advance hyperphosphatemia treatment · publication: PharmaTimesgoogle_news · 10/1/2026
Pressurl: https://news.google.com/rss/articles/CBMivgFBVV95cUxOQm95WnVpcXNwTzNfR0RnMWxMdWlDZmhkVC1uUHM2QXFocHF2M3hqOXp6RmU1cnRvcEtYTUw1cDNrQzBjVTlHZ0xWQmpHR3dJdEpNLVpOaVhXMUtJRDE1X2ZvXzFLUHNmZ3ZvU2NtZ1hBQ1B1ZVpXOF9zY2JGY3Vydi1rNEpsUHdtWnI0LWszU2hxbWo0cExORkdtME9iRjJqUnVYS2c1anNSYnlXSUJKVy1XaHUxZWh4bnYzV1lR?oc=5 · headline: R1 zooms out of stealth with $77.5M series A to advance chronic kidney disease treatment · publication: Fierce Biotechgoogle_news · 10/1/2026
Pressurl: https://news.google.com/rss/articles/CBMiqAFBVV95cUxOd19BSUtoX1R5Z1ZsRTZqMFFoeXpfLWdyY2s2WVY1WmlBbURXLU1SclR4eS0weXk3Q3NwTzFQdjBCenEtYlRXQklweHdWWG1sUkdvc3ZQUzM4Wm52QWZvUUl5S0ZfTk5YeTNvb1lpZDROWTZIZjN2X0lYQVhJSlN2QVJ3WGI2YkpKS0VoOHc1QXJIUExpVDhTUEtVeVVfeFR1TkFMLVZSWVM?oc=5 · headline: R1 Therapeutics begins global phase 2b trial of AP306 for hyperphosphatemia · publication: PharmaTimesgoogle_news · 10/1/2026
Pressurl: https://news.google.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?oc=5 · headline: R1 Therapeutics expands Series A to $80.5 million to advance global Phase 2b program in hyperphosphatemia · publication: The Manila Timesgoogle_news · 10/1/2026